Many women are familiar with the brand name BOTOX® Cosmetic (onabotulinumtoxinA), but a new study from SheSpeaks™, an online community of women, reveals what they really want to know about it.1 To address the most common questions women have – and there are nearly 10 million women who are considering treatment2 – Allergan Inc., maker of BOTOX® Cosmetic, teamed up with SheSpeaks to identify these questions and provide answers.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7334951-allergan-shespeaks-survey-reveals-what-u-s-women-really-want-to-know-about-botox-cosmetic/
The U.S. Food and Drug Administration (FDA) is alerting pregnant women about the risks of listeriosis, a foodborne disease that can severely affect a pregnant women and her unborn child.
Listeria can affect all races and ethnic groups, but pregnant women are 10 times more likely than other healthy adults to get listeriosis due to hormonal changes that affect the immune system during pregnancy. Pregnant Hispanic women are about 24 times more likely than the general population to get listeriosis. A pregnant mother may pass Listeria onto her unborn baby without even knowing it because she doesn’t feel sick at all, yet the disease can lead to miscarriage, stillbirth, premature labor, the delivery of a low birthweight infant, a wide range of health problems for a newborn, or even infant death.
To view the multimedia release go to:
https://www.multivu.com/players/English/7953451-fda-listeriosis-prevention-pregnant-women/
Bu videoda birçok akıllı maymunlar ile yapılan testleri görebilirsiniz. Bazıları işaret dilinde konuşuyor, bazıları bilgisayar ile anlaşıyor, bazıları lexigram kullanıyor, birçoğu söylenenleri anlıyor, kısacası iyi seyirler.
This Sunday, millions of kids across America will celebrate their fathers and the contributions they have made to their lives. To coincide with Father’s Day, the Ad Council, U.S. Department of Health and Human Services and the National Responsible Fatherhood Clearinghouse have launched a new series of public service advertisements (PSAs) that encourage dads to recognize the critical role they play in their children’s lives, and provide tools and information to help them get more involved with their kids.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7552651-ad-council-fatherhood-psa/
Jean Cartwright Rhodes is struggling to come to grips with the death of her childhood best friend, Hope.
Twenty-nine years later, Jean fights for her sanity as she confronts the dark web of intrigue set in motion by
a split-second decision in the aftermath of the tragedy. Learn more here, http://bit.ly/1jXhhry Fiction, Thriller, Crime, Mystery
there are unexpeced things frequently happen.( Max Phong, Poy Kim, Tuan Keyl, Bao Ho, Bao Duong) Written & Directed by Max Phong, Executive Producers Max Phong, Produced by Max Phong, Poy Kim CAST Max Phong-Pugilist, Poy Kim-musician, Tuan keyl, Bao Ho, Bao Duong ♦My Facebook: https://www.facebook.com/max.phong♦My Instagram: https://instagram.com/maxphongg/
Oro Valley Audiology
2542 E Vistoso Commerce Loop Rd, Tucson, AZ 85755, USA
(520) 825-4770
http://hearintucson.com
https://www.google.com/maps?cid=7471816986561274177
https://www.google.com/search?q=Oro+Valley+Audiology&kponly&kgmid=/g/1thx4hd3
As the name suggests, and audiologist is a health-care professional who concentrates on the medical diagnoses, recognition, tracking and treatment of conditions of the auditory and vestibular parts of the ear. These specialists dispense hearing aids, manage and fix up hearing problems and evaluate candidacy for cochlear implants. An audiologist helps style and carry out individual and industrial hearing safety programs, newborn hearing screening programs, and school hearing screening programs.
Audiologists have training in anatomy and physiology, hearing aids, cochlear implants, electrophysiology, acoustics, psychophysics, neurology, vestibular function and evaluation, balance disorders, therapy and indication language. Unfortunately, hearing loss is prevalent throughout the U.S.
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.
It is estimated that almost 40 percent of men and women in the U.S. will be diagnosed with cancer sometime during their lifetime. Kommah, who was diagnosed at age 29, now has her health and her son, thanks to discoveries made at City of Hope, where scientists and doctors turn laboratory breakthroughs into treatments that defeat cancer.
Today, the nonprofit research and comprehensive cancer center near Los Angeles is rolling out a new initiative that builds on its legacy of discovery to let people know that City of Hope not only offers a uniquely patient-centric, integrated approach to care, but also with the help of donors and volunteers, it is pursuing research that will change the future of medicine.
To view the multimedia release go to:
http://www.multivu.com/players/English/7665051-city-of-hope-miracle-science-soul-campaign/
Today marks the official one-year countdown to the arrival of MSC Seaside in Miami, and MSC Cruises — the Swiss-based world’s largest privately-owned cruise line and market leader in Europe, South America and South Africa — is marking the occasion with remarkable savings and value-adds for travelers.
MSC Seaside, the most anticipated ship coming to Miami in 2017, is the first of up to three MSC Cruises next-generation “Seaside” class of cruise ships and is set to arrive in the U.S. in December 2017. With an ultramodern and innovative “condo-on-the-beach” design, the ship has been crafted specifically for warm weather, offering sun worshippers one of the highest ratios of outdoor space at sea. She will sail from Miami to the Caribbean year-round and bring guests closer to the sea than ever before with a 360° outdoor promenade including a variety of outdoor restaurants and bars.
To view the multimedia release go to:
http://www.multivu.com/players/English/7807951-countdown-to-msc-seaside/
